BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18190601)

  • 1. Screening of FDA-Approved Drug Library Identifies Adefovir Dipivoxil as Highly Potent Inhibitor of T Cell Proliferation.
    Voss L; Guttek K; Reddig A; Reinhold A; Voss M; Schraven B; Reinhold D
    Front Immunol; 2020; 11():616570. PubMed ID: 33488629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease.
    McKinney EF; Lyons PA; Carr EJ; Hollis JL; Jayne DR; Willcocks LC; Koukoulaki M; Brazma A; Jovanovic V; Kemeny DM; Pollard AJ; Macary PA; Chaudhry AN; Smith KG
    Nat Med; 2010 May; 16(5):586-91, 1p following 591. PubMed ID: 20400961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANCA-associated systemic vasculitis initially mimicking peripheral neuropathy in an elderly woman.
    He X; Wang Y; Li X
    Pak J Med Sci; 2024; 40(5):1042-1045. PubMed ID: 38827870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesylate use in refractory eosinophilic granulomatosis with polyangiitis: a literature review and a case report.
    Beketova TV; Volkov MY; Naryshkin EA; Novoselova TM; Nasonov EL
    Clin Rheumatol; 2018 Jun; 37(6):1729-1735. PubMed ID: 29564565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of immunological profiles in patients with chronic myeloid leukemia in the course of treatment.
    Humlová Z; Klamová H; Janatková I; Malíčková K; Králíková P; Sterzl I; Roth Z; Hamšíková E; Vonka V
    Clin Dev Immunol; 2010; 2010():137320. PubMed ID: 21197073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach to the diagnosis and management of systemic vasculitis.
    Miller A; Chan M; Wiik A; Misbah SA; Luqmani RA
    Clin Exp Immunol; 2010 May; 160(2):143-60. PubMed ID: 20070316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA-associated vasculitis: from bench research to novel treatments.
    Pallan L; Savage CO; Harper L
    Nat Rev Nephrol; 2009 May; 5(5):278-86. PubMed ID: 19384329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides.
    Rasmussen N; Petersen J
    J Autoimmun; 1993 Apr; 6(2):227-36. PubMed ID: 8499060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin.
    Jayne DR; Esnault VL; Lockwood CM
    J Autoimmun; 1993 Apr; 6(2):207-19. PubMed ID: 8499059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib mesylate, a new kid on the block for the treatment of anti-neutrophil cytoplasmic autoantibodies-associated vasculitis?
    Kälsch AI; Soboletzki M; Schmitt WH; van der Woude FJ; Hochhaus A; Yard BA; Birck R
    Clin Exp Immunol; 2008 Mar; 151(3):391-8. PubMed ID: 18190601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.
    Marinaki S; Neumann I; Kälsch AI; Grimminger P; Breedijk A; Birck R; Schmitt W; Waldherr R; Yard BA; Van Der Woude FJ
    Clin Exp Immunol; 2005 Apr; 140(1):181-91. PubMed ID: 15762890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro.
    Cwynarski K; Laylor R; Macchiarulo E; Goldman J; Lombardi G; Melo JV; Dazzi F
    Leukemia; 2004 Aug; 18(8):1332-9. PubMed ID: 15190258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy.
    Christensson M; Pettersson E; Sundqvist KG; Christensson B
    Clin Nephrol; 2000 Dec; 54(6):435-42. PubMed ID: 11140803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent T-cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis.
    Marinaki S; Kälsch AI; Grimminger P; Breedijk A; Birck R; Schmitt WH; Weiss C; van der Woude FJ; Yard BA
    Nephrol Dial Transplant; 2006 Jul; 21(7):1825-32. PubMed ID: 16567340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms.
    O'Sullivan S; Naot D; Callon K; Porteous F; Horne A; Wattie D; Watson M; Cornish J; Browett P; Grey A
    J Bone Miner Res; 2007 Nov; 22(11):1679-89. PubMed ID: 17663639
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.